David L. Wyles
AuthID: R-00F-E89
1
TITLE: Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin Full Text
AUTHORS: Alqahtani, S; Ozaras, R; Isakov, V; Wyles, D; Ferenci, P; Feld, JJ; Calinas, F; Gschwantler, M; Gane, E; Crawford, D; Jacobson, IM; Dumas, EO; King, M; Sulkowski, M;
PUBLISHED: 2017, SOURCE: JOURNAL OF VIRAL HEPATITIS, VOLUME: 24, ISSUE: 4
AUTHORS: Alqahtani, S; Ozaras, R; Isakov, V; Wyles, D; Ferenci, P; Feld, JJ; Calinas, F; Gschwantler, M; Gane, E; Crawford, D; Jacobson, IM; Dumas, EO; King, M; Sulkowski, M;
PUBLISHED: 2017, SOURCE: JOURNAL OF VIRAL HEPATITIS, VOLUME: 24, ISSUE: 4
INDEXED IN: 
WOS
WOS2
TITLE: Time to Viral Suppression is Not Related to Achievement of SVR12 in HCV GT1-infected Patients Treated with ABT-450/r/Ombitasvir and Dasabuvir With or Without Ribavirin
AUTHORS: Mark S Sulkowski; Michael W Fried; Resat Ozaras; Vasily Isakov; David L Wyles; Peter Ferenci; Jordan J Feld; Filipe Calinas; Michael Gschwantler; Martin King; Tolga Baykal; Edward J Gane;
PUBLISHED: 2014, SOURCE: 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases in HEPATOLOGY, VOLUME: 60
AUTHORS: Mark S Sulkowski; Michael W Fried; Resat Ozaras; Vasily Isakov; David L Wyles; Peter Ferenci; Jordan J Feld; Filipe Calinas; Michael Gschwantler; Martin King; Tolga Baykal; Edward J Gane;
PUBLISHED: 2014, SOURCE: 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases in HEPATOLOGY, VOLUME: 60
INDEXED IN: WOS
WOS